Events, By Category and Date:
» Go to news mainConcerns over clinical trials with pregnant women could delay a Zika vaccine
Posted by nte on
February 5, 2016
in
In Action
Françoise Baylis calls for pregnant women to be included in clinical trials of Zika virus vaccines at a later stage in the clinical testing process and thinks the pharmaceutical needs of pregnant women are not addressed owing to the current industry normal practice of exluding them from testing. Read and list to more.
Recent News
- On what basis did Health Canada approve OxyContin in 1996? A retrospective analysis of regulatory data
- Matthew Herder Resigns from Patented Medicine Prices Review Board
- Permissive regulation: A critical review of the regulatory history of buprenorphine formulations in Canada
- Fair pricing of “old” orphan drugs: considerations for Canada’s orphan drug policy
- Podcast or Perish: Episode 040: Françoise Baylis
- Bioethicist Françoise Baylis asks why humans think 'they can just take everything'
- Killam Prize winners discuss research in Canada
- World‑renowned Dalhousie bioethicist and battery pioneer win prestigious Killam Prize